Examines the impact of gammalinolenic acid on cytokine secretion in monocytes, suggesting a potential treatment for rheumatoid arthritis.
Background Oils enriched in gammalinolenic acid, an unsaturated fatty acid, reduce joint pain and swelling in patients with rheumatoid arthritis. The cytokines interleukin-1β and tumor necrosis factor-α appear to contribute directly to joint tissue damage in patients with rheumatoid arthritis. Agents designed to interfere with the actions of interleukin-1β and tumor necrosis factor-α are being used to treat rheumatoid arthritis. Methods We examined the influence of gammalinolenic acid added to cells in vitro and administered orally in vivo on interleukin-1β and tumor necrosis factor-α secretion from activated human peripheral blood monocytes. Secretion of both cytokines was reduced by gammalinolenic acid. Administration of safflower oil as a polyunsaturated fatty acid control devoid of gammalinolenic acid did not change secretion of either cytokine. Conclusion Suppression of IL-β and TNF-α secretion by activated cells may be one mechanism whereby gammalinolenic acid suppresses synovitis in patients with rheumatoid arthritis.
No takes yet. Share an insight, caveat, or question.
DeLuca et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: